Vivimed Labs LimitedVIVIMEDLABCorporate

Pharmaceuticals Latest results: Mar 2026 1 quarters of data

₹5.42

MCap ₹45 Cr

AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.

₹8 Cr

Sales · Mar 2026

₹-137 Cr

Operating Profit · Mar 2026

-1815.0%

OPM % · Mar 2026

₹-142 Cr

Net Profit · Mar 2026

₹-17.14

EPS · Mar 2026

📝 Vivimed Labs Limited — results explained

Quarter ended March 2026 (Q4 FY26)

Vivimed Labs Limited reported revenue of ₹8 crore for the quarter ended March 2026 (Q4 FY26).

The company reported a net loss of ₹142 crore. Earnings per share (EPS) came in at ₹-17.14.

Operating profit stood at ₹-137 crore — an operating margin (OPM) of -1815.0%.

Valuation snapshot

At the current price of ₹5.42, VIVIMEDLAB has a market capitalisation of ₹45 crore.

Within the Pharmaceuticals industry, it is the 25th-largest of the 83 companies we track by market value.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close

Valuation

Market Cap ?

₹45 Cr

Current Price ?

₹5.4

P/E ?

N/A

Industry P/E ?

22.50

P/B ?

-0.40

P/S ?

N/A

P/FCF ?

N/A

Enterprise Value ?

₹433 Cr

EV/EBITDA ?

N/A

PEG ?

N/A

Earnings Yield ?

N/A

Dividend Yield ?

N/A

Profitability & Returns

Sales (TTM) ?

N/A

OPM ?

N/A

Profit after tax (TTM) ?

N/A

EPS (TTM) ?

N/A

ROCE ?

N/A

ROE ?

N/A

ROA ?

N/A

Growth

Sales — latest qtr ?

₹8 Cr

PAT — latest qtr ?

₹-142 Cr

YoY qtr sales growth ?

N/A

YoY qtr profit growth ?

N/A

Sales growth (3y) ?

N/A

Sales growth (5y) ?

N/A

Profit growth (3y) ?

N/A

Profit growth (5y) ?

N/A

Financial Health

Debt ?

₹388 Cr

Debt to Equity ?

-3.46

Interest Coverage ?

N/A

Ownership

Promoter holding ?

N/A

Change in promoter holding ?

N/A

FII holding ?

N/A

DII holding ?

N/A

Market

Return 3 months ?

7.5%

Return 6 months ?

-19.0%

🗓️ Quarterly results (1 quarters · ₹ Cr)

same fiscal quarter as Mar bestweakest per row · for costs (interest, NPAs) low is best Highlight

Metric	Mar 2026	YoY %	QoQ %
Sales	8	—	—
Operating Profit	-137	—	—
Other Income	0	—	—
Interest	1	—	—
Depreciation	4	—	—
Profit Before Tax	-142	—	—
Net Profit	-142	—	—
EPS	-17.14	—	—
OPM %	-1815.0%	—	—

📆 Annual results (₹ Cr, FY = Apr–Mar)

Annual rollup not yet available We need at least 3 quarters of a fiscal year to compute annual figures. This symbol does not yet have a complete fiscal year in our database.

🏛️ Balance Sheet (latest 1 periods)

Metric	Mar 2026	% Chg
Equity Capital	17	—
Reserves	-129	—
Borrowings	388	—
Other Liabilities	226	—
Total Liabilities	502	—
Fixed Assets	286	—
CWIP	17	—
Investments	56	—
Other Assets	142	—
Total Assets	502	—

📦 Working Capital (latest 1 periods)

Metric	Mar 2026	% Chg
Inventories	11	—
Trade Receivables	43	—
Trade Payables	52	—

💧 Cash Flow (latest 1 periods)

Metric	Mar 2026	% Chg
Cash from Operating Activity	4	—
Cash from Investing Activity	-0	—
Cash from Financing Activity	-5	—
Net Cash Flow	-0	—

⚖️ Peer comparison

Industry: Pharmaceuticals · top 25 of 83 companies · full page →

#	Company	CMP	MCap (Cr)	P/E	Sales TTM	NP TTM	OPM%	NPM%	ROE%	ROCE%	D/E	Sales YoY%	NP YoY%	Qtr Rev Δ%	Qtr NP Δ%
1	SUDEEPPHRM Sudeep Pharma	₹1,033.30	11,671	61.8	709	189	35.4%	26.7%	19.8%	—	0.20	—	—	20.9%	10.8%
2	SPARC Sun Pharma	₹185.08	6,006	3.7	1,931	1,636	84.7%	84.7%	113.4%	164.0%	0.00	2512.3%	553.9%	282.1%	67.8%
3	GUJTHEM Gujarat Themis	₹412.60	5,370	92.3	173	48	47.3%	27.8%	—	—	—	8.6%	-6.1%	21.6%	23.0%
4	539997 Kwality Pharmaceuticals	₹2,652.10	3,348	34.0	553	81	24.4%	14.6%	—	—	—	35.7%	71.8%	46.3%	113.5%
5	524632 Shukra Pharmaceuticals	₹80.95	2,403	99.9	75	36	65.0%	48.2%	—	—	—	74.0%	130.1%	336.4%	1359.2%
6	FERMENTA Fermenta Biotech	₹465.00	1,333	20.9	501	64	18.9%	12.7%	—	—	—	—	—	-17.9%	-30.6%
7	506414 Fermenta Biotech	₹552.60	1,313	27.2	511	59	17.6%	11.5%	—	—	—	11.9%	-6.6%	-10.4%	-56.7%
8	AHCL Anlon Healthcare	₹24.66	1,311	31.6	280	42	24.5%	14.9%	—	—	—	—	—	—	—
9	541096 Bharat Parenterals	₹1,525.00	1,045	—	395	-10	8.4%	-2.4%	—	—	—	1.5%	37.5%	110.9%	237.4%
10	540737 Shree Ganesh	₹796.30	844	84.4	92	12	27.6%	13.2%	—	—	—	0.7%	-23.0%	-23.2%	-67.1%
11	AMANTA Amanta Healthcare	₹163.87	636	43.5	291	15	20.4%	5.0%	—	—	—	—	—	5.4%	-5.6%
12	539730 Fredun Pharmaceuticals	₹827.85	611	10.3	747	44	14.7%	5.9%	—	—	—	40.1%	90.0%	90.2%	88.1%
13	500422 Transchem Ltd-$	₹38.00	474	6.9	—	7	—	—	—	—	—	-100.0%	-17.8%	—	245.6%
14	HALEOSLABS Haleos Labs	₹1,525.00	461	21.0	324	15	12.6%	4.7%	—	—	—	-3.2%	-4.9%	-11.6%	-58.0%
15	524731 Jenburkt Pharmaceuticals	₹865.75	380	11.6	170	33	23.6%	19.4%	—	—	—	11.8%	6.1%	-1.4%	-26.4%
16	543616 Trident Lifeline	₹279.85	363	11.0	166	31	26.2%	18.4%	—	—	—	—	—	117.1%	134.7%
17	512600 Astal Laboratories	₹75.00	308	32.3	170	10	8.8%	5.7%	—	—	—	142.9%	-9.0%	56.0%	77.4%
18	524828 BDH Industries	₹336.80	300	16.6	100	12	15.3%	11.7%	—	—	—	44.3%	16.6%	20.2%	48.8%
19	500009 Ambalal Sarabhai	₹38.73	297	21.9	206	14	7.1%	6.6%	—	—	—	3.1%	261.1%	8.0%	-51.6%
20	531739 Gennex Laboratories	₹13.87	255	19.0	183	21	14.4%	11.3%	—	—	—	24.9%	15.5%	16.6%	-6.9%
21	524790 Everest Organics	₹159.20	252	29.4	191	5	10.3%	2.8%	—	—	—	23.0%	527.7%	-10.0%	-21.1%
22	532039 Zenotech Laboratories	₹64.90	234	—	41	-4	8.1%	-10.5%	—	—	—	1.3%	-119.2%	-36.4%	-206.3%
23	524506 Coral Laboratories	₹680.20	228	12.7	97	19	19.2%	19.9%	—	—	—	-25.3%	-32.2%	57.4%	110.5%
24	530163 Kerala Ayurveda	₹310.20	225	—	125	-26	-14.9%	-20.8%	—	—	—	9.0%	-16.8%	-21.3%	-477.8%
25	VIVIMEDLAB Vivimed Labs	₹6.45	53	—	—	—	—	—	—	—	-1.89	—	—	—	—

❓ Frequently asked questions

What was Vivimed Labs Limited's revenue in Q4 FY26?